ProfileGDS2971 / 9.4.4.10
TitleHemiasterlin analog HTI-286 effect on docetaxel-resistant prostate cancer cell line
OrganismHomo sapiens


HTI-286 docetaxel GSM206100 GSM206166 GSM206167 GSM206168 GSM206169 GSM206170 GSM206357 GSM206358 GSM206359 GSM206360 GSM206361 GSM206362 26% 41% 14% 19% 37% 65% 49% 12% 93% 29% 66% 22% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM206100HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 1)-0.32633426
GSM206166HTI-286 in docetaxel-refractory prostate cancer (Dye Flip 1)-0.058970141
GSM206167HTI-286 in docetaxel-refractory prostate cancer Biological Replicate 2-0.55593314
GSM206168HTI-286 in docetaxel-refractory prostate cancer (Biological Replicate 3)-0.60043819
GSM206169HTI-286 in docetaxel-refractory prostate cancer (Dye flip2)-0.18261337
GSM206170HTI-286 in docetaxel-refractory prostate cancer (dyeflip3)0.18931465
GSM206357HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip1)0.020738749
GSM206358HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate1)-1.3656212
GSM206359HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip2)1.6024393
GSM206360HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate2)-0.32958729
GSM206361HTI-286 in docetaxel-refractory prostate cancer_docet (Dye flip3)0.27939766
GSM206362HTI-286 in docetaxel-refractory prostate cancer_docet (Biological Replicate3)-0.45835522